These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25232160)

  • 1. Whole-genome comparison of Aspergillus fumigatus strains serially isolated from patients with aspergillosis.
    Hagiwara D; Takahashi H; Watanabe A; Takahashi-Nakaguchi A; Kawamoto S; Kamei K; Gonoi T
    J Clin Microbiol; 2014 Dec; 52(12):4202-9. PubMed ID: 25232160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing.
    Abdolrasouli A; Rhodes J; Beale MA; Hagen F; Rogers TR; Chowdhary A; Meis JF; Armstrong-James D; Fisher MC
    mBio; 2015 Jun; 6(3):e00536. PubMed ID: 26037120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase.
    Hagiwara D; Arai T; Takahashi H; Kusuya Y; Watanabe A; Kamei K
    Emerg Infect Dis; 2018 Oct; 24(10):1889-1897. PubMed ID: 30226177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J; Li H; Li R; Bu D; Wan Z
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
    J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing.
    Camps SM; Dutilh BE; Arendrup MC; Rijs AJ; Snelders E; Huynen MA; Verweij PE; Melchers WJ
    PLoS One; 2012; 7(11):e50034. PubMed ID: 23226235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis.
    Ballard E; Melchers WJG; Zoll J; Brown AJP; Verweij PE; Warris A
    Fungal Genet Biol; 2018 Apr; 113():1-13. PubMed ID: 29477713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
    J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
    van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
    J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
    Amorim A; Guedes-Vaz L; Araujo R
    Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
    Hurst SF; Berkow EL; Stevenson KL; Litvintseva AP; Lockhart SR
    J Antimicrob Chemother; 2017 Sep; 72(9):2443-2446. PubMed ID: 28575384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Environmental Azole Resistance Mutation in
    Zhang J; Snelders E; Zwaan BJ; Schoustra SE; Meis JF; van Dijk K; Hagen F; van der Beek MT; Kampinga GA; Zoll J; Melchers WJG; Verweij PE; Debets AJM
    mBio; 2017 Jun; 8(3):. PubMed ID: 28655821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.